Biotech ETF over single-stock bets
The case was made that for biotech investing, a broad sector ETF is preferable to picking individual stocks due to the unpredictable nature of drug development successes.
Sign in to read the full idea
The argument, what validates it, the risks discussed and hearing it from the source are for signed-in members. Free accounts read 3 ideas in full a day. No card required.